Track topics on Twitter Track topics that are important to you
The French pharma is eyeing a 2020 launch but will face a challenging U.S. market given restrictions on the vaccine's use.
Original Article: Sanofi's dengue vaccine wins limited FDA approvalNEXT ARTICLE
A vaccine is a biological preparation that improves immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism, and is often made from weakened or killed forms of the microbe, its toxins or one ...